A case of multi-metastatic melanoma with RAF1 fusion: a surprising response to anti-MEK therapy
A. Pacaud, Samuel Amintas, Lise Boussemart, David Cappellen, E. Gérard
Topics & Concepts
DabrafenibTrametinibMelanomaMedicineMEK inhibitorCancer researchMetastatic melanomaOncologyTargeted therapyGNAQInternal medicineMutationMAPK/ERK pathwayVemurafenibCancerBiologyGeneKinaseGeneticsMelanoma and MAPK PathwaysCutaneous Melanoma Detection and ManagementCancer Immunotherapy and Biomarkers